Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes [Phase 3]
An update on the long-term safety results of Biphasic Insulin Aspart 30 in children with Type 1 diabetes from a Phase 3 trial.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of Insulin Detemir in Type 1 Diabetes [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of insulin detemir in type 1 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes [Phase 3]
Phase 3 trial evaluating the efficacy and safety of Biphasic Insulin Aspart 30 in adults with type 1 or type 2 diabetes; the study has been …
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Safety of Insulin Detemir in Children With Type 1 Diabetes [Phase 3]
Phase 3 clinical trial update assessing the safety of insulin detemir in children with Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 Diabetes [Phase 3]
A Phase 3 trial comparing insulin detemir with insulin semilente in type 1 diabetes has completed. The sponsor is Novo Nordisk.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Efficacy of Coordinated Insulin Boluses in Type 1 Diabetic Patients [Phase 4]
A Phase 4 trial evaluating the efficacy of coordinated insulin boluses in Type 1 diabetes patients has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes [Phase 3]
This Phase 3 clinical trial update reports on the long-term safety of insulin aspart used in the treatment of Type 1 diabetes. The study, sp…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes [Phase 4]
A Phase 4 trial evaluating the safety and efficacy of insulin aspart in children with Type 1 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT) [Phase 4]
A Phase 4 clinical trial update assessing the optimal insulin correction factor for managing post-exercise hyperglycemia in adults with Type…
-
CLINICAL_TRIALS withdrawal · 2017-02-15Clinical Trial Update: Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression [Phase 1]
A Phase 1 clinical trial evaluating pancreatic islet cell transplantation after kidney transplantation using a novel immunosuppression appro…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: A Trial Investigating the Total Exposure of NN5401 (Insulin Degludec/Insulin Aspart) in Children, Adolescents and Adult Subjects With Type 1 Diabetes [Phase 1]
This Phase 1 trial update evaluates total exposure of NN5401 (insulin degludec/insulin aspart) in children, adolescents, and adults with Typ…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes [Phase 2]
Phase 2 study evaluating safety, pharmacokinetics (PK) and pharmacodynamics (PD) of dapagliflozin in individuals with Type 1 Diabetes Mellit…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Effect of NN5401 in Japanese Subjects With Type 1 Diabetes [Phase 1]
This update reports the completion of a Phase 1 study of NN5401 in Japanese subjects with Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: A Trial Investigating the Exposure of NN5401 in Young Adults and Elderly Subjects With Type 1 Diabetes [Phase 1]
A Phase 1 trial evaluating the exposure of NN5401 in young adults and elderly subjects with Type 1 diabetes has completed.
-
CLINICAL_TRIALS research · 2017-02-10Clinical Trial Update: A Trial Investigating the Pharmacodynamic Properties of NN5401 in Subjects With Type 1 Diabetes [Phase 1]
Phase 1 clinical trial evaluating the pharmacodynamic properties of NN5401 in subjects with Type 1 diabetes mellitus; the study sponsored by…
-
CLINICAL_TRIALS trial_result · 2017-02-10Clinical Trial Update: Investigation of the Response Relationship of NN5401 in Type 1 Diabetics [Phase 1]
A Phase 1 clinical trial evaluating NN5401 in people with Type 1 diabetes mellitus has completed, according to sponsor Novo Nordisk A/S.
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
The clinical trial evaluating liraglutide as an add-on treatment for Type 1 diabetes mellitus has completed.
-
CLINICAL_TRIALS withdrawal · 2017-02-09Clinical Trial Update: Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes [Phase 3]
A Phase 3 trial evaluating the anti-diabetic effects of liraglutide in adolescents and young people with Type 1 diabetes mellitus has been w…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Clinical Evaluation of BD NEXT Pen Needle
This clinical trial update indicates the BD NEXT Pen Needle clinical evaluation has completed in participants with type 1 and type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics [Phase 1]
Phase 1 trial evaluating a diabetes vaccine in newly diagnosed diabetics has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Comparison of NovoFine® Needles (4 mm vs. 6 mm) [Phase 2]
A Phase 2 clinical trial comparing NovoFine needles of 4 mm versus 6 mm in people with diabetes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Proleukin and Rapamune in Type 1 Diabetes [Phase 1]
Phase 1 clinical trial update evaluating the combination of Proleukin (aldesleukin) and Rapamune (sirolimus) in Type 1 diabetes; the study h…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes [Phase 1]
Phase 1 trial evaluating whether adding liraglutide to insulin alters glucagon response to hypoglycemia in individuals with Type 1 diabetes;…
-
CLINICAL_TRIALS research · 2017-02-08Clinical Trial Update: Observational Study of NovoPen Echo® on Safety and Treatment Satisfaction in Children and Adolescents With Type 1 Diabetes
Observational study assessing safety and treatment satisfaction of NovoPen Echo in children and adolescents with Type 1 diabetes.
-
CLINICAL_TRIALS withdrawal · 2017-02-08Clinical Trial Update: Treatment With hOKT3gamma1(Ala-Ala) in T1DM [Phase 2]
A Phase 2 clinical trial evaluating hOKT3gamma1(Ala-Ala) for Type 1 diabetes mellitus was terminated.